4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-21-029271
Director sold 10,000 shares at an average $126.43 ($1,264,348)
From the SEC's structured data for this filing
Trades in this filing
Bolzon Bradley J PhD · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-19 | Sale : show line 1 in the form | −3,504 | $125.67 | $440,345 | 155,327 | I |
| 2021-07-19 | Sale : show line 2 in the form | −4,472 | $126.41 | $565,289 | 150,855 | I |
| 2021-07-19 | Sale : show line 3 in the form | −1,324 | $127.36 | $168,619 | 149,531 | I |
| 2021-07-19 | Sale : show line 4 in the form | −700 | $128.71 | $90,094 | 148,831 | I |
| Open-market sales · 10,000 sh · avg $126.43 · $1,264,348 | ||||||
Loading xslF345X03/doc4.xml…